TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

Global and United States HIV-AIDS Testing Market Report & Forecast 2022-2028

Global and United States HIV-AIDS Testing Market Report & Forecast 2022-2028

  • Category:Life Sciences
  • Published on : 27 September 2022
  • Pages :115
  • Formats:
  • Report Code:SMR-7394036
OfferClick for best price

Best Price: $3480

HIVAIDS Testing Market Size, Share 2022


Market Analysis and Insights: Global HIVAIDS Testing Market

The global HIVAIDS Testing market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global HIVAIDS Testing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global HIVAIDS Testing market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global HIVAIDS Testing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global HIVAIDS Testing market.

Global HIVAIDS Testing Scope and Market Size

HIV-AIDS Testing market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global HIV-AIDS Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.

For United States market, this report focuses on the HIV-AIDS Testing market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

Segment by Type

Kits and Reagents

Instruments

Others

Segment by Application

Hospitals

Private Diagnostics Laboratories

Academic and Research Institutes

Others

By Region

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Indonesia

Thailand

Malaysia

Philippines

Vietnam

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

U.A.E

By Company

Abbott

Affymetrix

Beckman Coulter/Danaher

Becton Dickinson

bioMerieux

Bio-Rad

Cepheid

Diamedix

DiaSorin

Eiken Chemical

Elitech Group

Enzo Biochem

Fujirebio

Lonza

Roche

Scienion

Sequenom

SeraCare

Siemens

Takara Bio

The information for each competitor/Company Profile includes:

  • Company Overview
  • Business Strategy
  • Key Product Offerings
  • Financial Performance
  • Key Performance Indicators
  • Risk Analysis
  • Recent Development
  • Regional Presence
  • SWOT Analysis 

The content of the study subjects includes a total of 15 chapters:

Chapter 1, describes HIVAIDS Testing product scope, market overview, market opportunities, market driving force, and market risks.

Chapter 2, profiles the top manufacturers of HIVAIDS Testing, with price, sales, revenue, and global market share of HIVAIDS Testing from 2019 to 2022.

Chapter 3, the HIVAIDS Testing competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the HIVAIDS Testing breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.

Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.

Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the HIVAIDS Testing market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.

Chapter 12, the key raw materials and key suppliers, and industry chain of HIVAIDS Testing.

Chapter 13, 14, and 15, to describe HIVAIDS Testing sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Key Indicators Analysed:

  • Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
  • Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
  • Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
  • Opportunities and Drivers: Identifying the Growing Demands and New Technology
  • Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

Reasons to Purchase this Report:

  • Estimates 2022-2027 2021-2025 HIVAIDS Testing Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
  • Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
  • Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
  • Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
  • Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
  • 1-year analyst support, along with the data support in excel format.

Research Methodology:

The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.

Report Attributes Report Details
Report Title Global and United States HIV-AIDS Testing Market Report & Forecast 2022-2028
Historical Year 2018 to 2022 (Data from 2010 can be provided as per availability)
Base Year 2021
Forecast Year 2029
Number of Pages 115 Pages
Customization Available Yes, the report can be customized as per your need.

TABLE OF CONTENTS

1 Study Coverage
1.1 HIV-AIDS Testing Revenue in HIV-AIDS Testing Business (2017-2022) & (US$ Million) Introduction
1.2 Global HIV-AIDS Testing Outlook 2017 VS 2022 VS 2028
1.2.1 Global HIV-AIDS Testing Market Size for the Year 2017-2028
1.2.2 Global HIV-AIDS Testing Market Size for the Year 2017-2028
1.3 HIV-AIDS Testing Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.3.1 The Market Share of United States HIV-AIDS Testing in Global, 2017 VS 2022 VS 2028
1.3.2 The Growth Rate of HIV-AIDS Testing Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4 HIV-AIDS Testing Market Dynamics
1.4.1 HIV-AIDS Testing Industry Trends
1.4.2 HIV-AIDS Testing Market Drivers
1.4.3 HIV-AIDS Testing Market Challenges
1.4.4 HIV-AIDS Testing Market Restraints
1.5 Study Objectives
1.6 Years Considered
2 HIV-AIDS Testing by Type
2.1 HIV-AIDS Testing Market Segment by Type
2.1.1 Kits and Reagents
2.1.2 Instruments
2.1.3 Others
2.2 Global HIV-AIDS Testing Market Size by Type (2017, 2022 & 2028)
2.3 Global HIV-AIDS Testing Market Size by Type (2017-2028)
2.4 United States HIV-AIDS Testing Market Size by Type (2017, 2022 & 2028)
2.5 United States HIV-AIDS Testing Market Size by Type (2017-2028)
3 HIV-AIDS Testing by Application
3.1 HIV-AIDS Testing Market Segment by Application
3.1.1 Hospitals
3.1.2 Private Diagnostics Laboratories
3.1.3 Academic and Research Institutes
3.1.4 Others
3.2 Global HIV-AIDS Testing Market Size by Application (2017, 2022 & 2028)
3.3 Global HIV-AIDS Testing Market Size by Application (2017-2028)
3.4 United States HIV-AIDS Testing Market Size by Application (2017, 2022 & 2028)
3.5 United States HIV-AIDS Testing Market Size by Application (2017-2028)
4 Global HIV-AIDS Testing Competitor Landscape by Company
4.1 Global HIV-AIDS Testing Market Size by Company
4.1.1 Top Global HIV-AIDS Testing Companies Ranked by Revenue (2021)
4.1.2 Global HIV-AIDS Testing Revenue by Player (2017-2022)
4.2 Global HIV-AIDS Testing Concentration Ratio (CR)
4.2.1 HIV-AIDS Testing Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Companies of HIV-AIDS Testing in 2021
4.2.3 Global HIV-AIDS Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global HIV-AIDS Testing Headquarters, Revenue in HIV-AIDS Testing Business (2017-2022) & (US$ Million) Type
4.3.1 Global HIV-AIDS Testing Headquarters and Area Served
4.3.2 Global HIV-AIDS Testing Companies Revenue in HIV-AIDS Testing Business (2017-2022) & (US$ Million) Type
4.3.3 Date of International Companies Enter into HIV-AIDS Testing Market
4.4 Companies Mergers & Acquisitions, Expansion Plans
4.5 United States HIV-AIDS Testing Market Size by Company
4.5.1 Top HIV-AIDS Testing Players in United States, Ranked by Revenue (2021)
4.5.2 United States HIV-AIDS Testing Revenue by Players (2020, 2021 & 2022)
5 Global HIV-AIDS Testing Market Size by Region
5.1 Global HIV-AIDS Testing Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global HIV-AIDS Testing Market Size by Region (2017-2028)
5.2.1 Global HIV-AIDS Testing Market Size by Region: 2017-2022
5.2.2 Global HIV-AIDS Testing Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America HIV-AIDS Testing Market Size YoY Growth 2017-2028
6.1.2 North America HIV-AIDS Testing Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific HIV-AIDS Testing Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific HIV-AIDS Testing Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe HIV-AIDS Testing Market Size YoY Growth 2017-2028
6.3.2 Europe HIV-AIDS Testing Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America HIV-AIDS Testing Market Size YoY Growth 2017-2028
6.4.2 Latin America HIV-AIDS Testing Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa HIV-AIDS Testing Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa HIV-AIDS Testing Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Abbott
7.1.1 Abbott Company Details
7.1.2 Abbott Business Overview
7.1.3 Abbott HIV-AIDS Testing Introduction
7.1.4 Abbott Revenue in HIV-AIDS Testing Business (2017-2022)
7.1.5 Abbott Recent Development
7.2 Affymetrix
7.2.1 Affymetrix Company Details
7.2.2 Affymetrix Business Overview
7.2.3 Affymetrix HIV-AIDS Testing Introduction
7.2.4 Affymetrix Revenue in HIV-AIDS Testing Business (2017-2022)
7.2.5 Affymetrix Recent Development
7.3 Beckman Coulter/Danaher
7.3.1 Beckman Coulter/Danaher Company Details
7.3.2 Beckman Coulter/Danaher Business Overview
7.3.3 Beckman Coulter/Danaher HIV-AIDS Testing Introduction
7.3.4 Beckman Coulter/Danaher Revenue in HIV-AIDS Testing Business (2017-2022)
7.3.5 Beckman Coulter/Danaher Recent Development
7.4 Becton Dickinson
7.4.1 Becton Dickinson Company Details
7.4.2 Becton Dickinson Business Overview
7.4.3 Becton Dickinson HIV-AIDS Testing Introduction
7.4.4 Becton Dickinson Revenue in HIV-AIDS Testing Business (2017-2022)
7.4.5 Becton Dickinson Recent Development
7.5 bioMerieux
7.5.1 bioMerieux Company Details
7.5.2 bioMerieux Business Overview
7.5.3 bioMerieux HIV-AIDS Testing Introduction
7.5.4 bioMerieux Revenue in HIV-AIDS Testing Business (2017-2022)
7.5.5 bioMerieux Recent Development
7.6 Bio-Rad
7.6.1 Bio-Rad Company Details
7.6.2 Bio-Rad Business Overview
7.6.3 Bio-Rad HIV-AIDS Testing Introduction
7.6.4 Bio-Rad Revenue in HIV-AIDS Testing Business (2017-2022)
7.6.5 Bio-Rad Recent Development
7.7 Cepheid
7.7.1 Cepheid Company Details
7.7.2 Cepheid Business Overview
7.7.3 Cepheid HIV-AIDS Testing Introduction
7.7.4 Cepheid Revenue in HIV-AIDS Testing Business (2017-2022)
7.7.5 Cepheid Recent Development
7.8 Diamedix
7.8.1 Diamedix Company Details
7.8.2 Diamedix Business Overview
7.8.3 Diamedix HIV-AIDS Testing Introduction
7.8.4 Diamedix Revenue in HIV-AIDS Testing Business (2017-2022)
7.8.5 Diamedix Recent Development
7.9 DiaSorin
7.9.1 DiaSorin Company Details
7.9.2 DiaSorin Business Overview
7.9.3 DiaSorin HIV-AIDS Testing Introduction
7.9.4 DiaSorin Revenue in HIV-AIDS Testing Business (2017-2022)
7.9.5 DiaSorin Recent Development
7.10 Eiken Chemical
7.10.1 Eiken Chemical Company Details
7.10.2 Eiken Chemical Business Overview
7.10.3 Eiken Chemical HIV-AIDS Testing Introduction
7.10.4 Eiken Chemical Revenue in HIV-AIDS Testing Business (2017-2022)
7.10.5 Eiken Chemical Recent Development
7.11 Elitech Group
7.11.1 Elitech Group Company Details
7.11.2 Elitech Group Business Overview
7.11.3 Elitech Group HIV-AIDS Testing Introduction
7.11.4 Elitech Group Revenue in HIV-AIDS Testing Business (2017-2022)
7.11.5 Elitech Group Recent Development
7.12 Enzo Biochem
7.12.1 Enzo Biochem Company Details
7.12.2 Enzo Biochem Business Overview
7.12.3 Enzo Biochem HIV-AIDS Testing Introduction
7.12.4 Enzo Biochem Revenue in HIV-AIDS Testing Business (2017-2022)
7.12.5 Enzo Biochem Recent Development
7.13 Fujirebio
7.13.1 Fujirebio Company Details
7.13.2 Fujirebio Business Overview
7.13.3 Fujirebio HIV-AIDS Testing Introduction
7.13.4 Fujirebio Revenue in HIV-AIDS Testing Business (2017-2022)
7.13.5 Fujirebio Recent Development
7.14 Lonza
7.14.1 Lonza Company Details
7.14.2 Lonza Business Overview
7.14.3 Lonza HIV-AIDS Testing Introduction
7.14.4 Lonza Revenue in HIV-AIDS Testing Business (2017-2022)
7.14.5 Lonza Recent Development
7.15 Roche
7.15.1 Roche Company Details
7.15.2 Roche Business Overview
7.15.3 Roche HIV-AIDS Testing Introduction
7.15.4 Roche Revenue in HIV-AIDS Testing Business (2017-2022)
7.15.5 Roche Recent Development
7.16 Scienion
7.16.1 Scienion Company Details
7.16.2 Scienion Business Overview
7.16.3 Scienion HIV-AIDS Testing Introduction
7.16.4 Scienion Revenue in HIV-AIDS Testing Business (2017-2022)
7.16.5 Scienion Recent Development
7.17 Sequenom
7.17.1 Sequenom Company Details
7.17.2 Sequenom Business Overview
7.17.3 Sequenom HIV-AIDS Testing Introduction
7.17.4 Sequenom Revenue in HIV-AIDS Testing Business (2017-2022)
7.17.5 Sequenom Recent Development
7.18 SeraCare
7.18.1 SeraCare Company Details
7.18.2 SeraCare Business Overview
7.18.3 SeraCare HIV-AIDS Testing Introduction
7.18.4 SeraCare Revenue in HIV-AIDS Testing Business (2017-2022)
7.18.5 SeraCare Recent Development
7.19 Siemens
7.19.1 Siemens Company Details
7.19.2 Siemens Business Overview
7.19.3 Siemens HIV-AIDS Testing Introduction
7.19.4 Siemens Revenue in HIV-AIDS Testing Business (2017-2022)
7.19.5 Siemens Recent Development
7.20 Takara Bio
7.20.1 Takara Bio Company Details
7.20.2 Takara Bio Business Overview
7.20.3 Takara Bio HIV-AIDS Testing Introduction
7.20.4 Takara Bio Revenue in HIV-AIDS Testing Business (2017-2022)
7.20.5 Takara Bio Recent Development
8 Research Findings and Conclusion
9 Appendix
9.1 Research Methodology
9.1.1 Methodology/Research Approach
9.1.2 Data Source
9.2 Author Details
9.3 Disclaimer

LIST OF TABLES & FIGURES

List of Tables
Table 1. HIV-AIDS Testing Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
Table 2. HIV-AIDS Testing Market Trends
Table 3. HIV-AIDS Testing Market Drivers
Table 4. HIV-AIDS Testing Market Challenges
Table 5. HIV-AIDS Testing Market Restraints
Table 6. Global HIV-AIDS Testing Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States HIV-AIDS Testing Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global HIV-AIDS Testing Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States HIV-AIDS Testing Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top HIV-AIDS Testing Companies in Global Market, Ranking by Revenue (2021)
Table 11. Global HIV-AIDS Testing Revenue by Player, (US$ Million), 2017-2022
Table 12. Global HIV-AIDS Testing Revenue Share by Player, 2017-2022
Table 13. Global HIV-AIDS Testing Companies Market Concentration Ratio (CR5 and HHI)
Table 14. Global HIV-AIDS Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in HIV-AIDS Testing as of 2021)
Table 15. Top Players of HIV-AIDS Testing in Global Market, Headquarters and Area Served
Table 16. Companies Revenue in HIV-AIDS Testing Business (2017-2022) & (US$ Million) Type
Table 17. Date of International Companies Enter into HIV-AIDS Testing Market
Table 18. Companies Mergers & Acquisitions, Expansion Plans
Table 19. Top HIV-AIDS Testing Players in United States Market, Ranking by Revenue (2021)
Table 20. United States HIV-AIDS Testing Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 21. United States HIV-AIDS Testing Revenue Share by Players, 2020, 2021 & 2022
Table 22. Global HIV-AIDS Testing Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 23. Global HIV-AIDS Testing Market Size by Region (2017-2022) & (US$ Million)
Table 24. Global HIV-AIDS Testing Market Size Forecast by Region (2023-2028) & (US$ Million)
Table 25. North America HIV-AIDS Testing Sales in Value by Country (2017-2028) & (US$ Million)
Table 26. Asia Pacific HIV-AIDS Testing Sales in Value by Region (2017-2028) & (US$ Million)
Table 27. Europe HIV-AIDS Testing Sales in Value by Country (2017-2028) & (US$ Million)
Table 28. Latin Americaa HIV-AIDS Testing Sales in Value by Country (2017-2028) & (US$ Million)
Table 29. Middle East and Africa HIV-AIDS Testing Sales in Value by Country (2017-2028) & (US$ Million)
Table 30. Abbott Company Details
Table 31. Abbott Business Overview
Table 32. Abbott HIV-AIDS Testing Product
Table 33. Abbott Revenue in HIV-AIDS Testing Business (2017-2022) & (US$ Million)
Table 34. Abbott Recent Development
Table 35. Affymetrix Company Details
Table 36. Affymetrix Business Overview
Table 37. Affymetrix HIV-AIDS Testing Product
Table 38. Affymetrix Revenue in HIV-AIDS Testing Business (2017-2022) & (US$ Million)
Table 39. Affymetrix Recent Development
Table 40. Beckman Coulter/Danaher Company Details
Table 41. Beckman Coulter/Danaher Business Overview
Table 42. Beckman Coulter/Danaher HIV-AIDS Testing Product
Table 43. Beckman Coulter/Danaher Revenue in HIV-AIDS Testing Business (2017-2022) & (US$ Million)
Table 44. Beckman Coulter/Danaher Recent Development
Table 45. Becton Dickinson Company Details
Table 46. Becton Dickinson Business Overview
Table 47. Becton Dickinson HIV-AIDS Testing Product
Table 48. Becton Dickinson Revenue in HIV-AIDS Testing Business (2017-2022) & (US$ Million)
Table 49. Becton Dickinson Recent Development
Table 50. bioMerieux Company Details
Table 51. bioMerieux Business Overview
Table 52. bioMerieux HIV-AIDS Testing Product
Table 53. bioMerieux Revenue in HIV-AIDS Testing Business (2017-2022) & (US$ Million)
Table 54. bioMerieux Recent Development
Table 55. Bio-Rad Company Details
Table 56. Bio-Rad Business Overview
Table 57. Bio-Rad HIV-AIDS Testing Product
Table 58. Bio-Rad Revenue in HIV-AIDS Testing Business (2017-2022) & (US$ Million)
Table 59. Bio-Rad Recent Development
Table 60. Cepheid Company Details
Table 61. Cepheid Business Overview
Table 62. Cepheid HIV-AIDS Testing Product
Table 63. Cepheid Revenue in HIV-AIDS Testing Business (2017-2022) & (US$ Million)
Table 64. Cepheid Recent Development
Table 65. Diamedix Company Details
Table 66. Diamedix Business Overview
Table 67. Diamedix HIV-AIDS Testing Product
Table 68. Diamedix Revenue in HIV-AIDS Testing Business (2017-2022) & (US$ Million)
Table 69. Diamedix Recent Development
Table 70. DiaSorin Company Details
Table 71. DiaSorin Business Overview
Table 72. DiaSorin HIV-AIDS Testing Product
Table 73. DiaSorin Revenue in HIV-AIDS Testing Business (2017-2022) & (US$ Million)
Table 74. DiaSorin Recent Development
Table 75. Eiken Chemical Company Details
Table 76. Eiken Chemical Business Overview
Table 77. Eiken Chemical HIV-AIDS Testing Product
Table 78. Eiken Chemical Revenue in HIV-AIDS Testing Business (2017-2022) & (US$ Million)
Table 79. Eiken Chemical Recent Development
Table 80. Elitech Group Company Details
Table 81. Elitech Group Business Overview
Table 82. Elitech Group HIV-AIDS Testing Product
Table 83. Elitech Group Revenue in HIV-AIDS Testing Business (2017-2022) & (US$ Million)
Table 84. Elitech Group Recent Development
Table 85. Enzo Biochem Company Details
Table 86. Enzo Biochem Business Overview
Table 87. Enzo Biochem HIV-AIDS Testing Product
Table 88. Enzo Biochem Revenue in HIV-AIDS Testing Business (2017-2022) & (US$ Million)
Table 89. Enzo Biochem Recent Development
Table 90. Fujirebio Company Details
Table 91. Fujirebio Business Overview
Table 92. Fujirebio HIV-AIDS Testing Product
Table 93. Fujirebio Revenue in HIV-AIDS Testing Business (2017-2022) & (US$ Million)
Table 94. Fujirebio Recent Development
Table 95. Lonza Company Details
Table 96. Lonza Business Overview
Table 97. Lonza HIV-AIDS Testing Product
Table 98. Lonza Revenue in HIV-AIDS Testing Business (2017-2022) & (US$ Million)
Table 99. Lonza Recent Development
Table 100. Roche Company Details
Table 101. Roche Business Overview
Table 102. Roche HIV-AIDS Testing Product
Table 103. Roche Revenue in HIV-AIDS Testing Business (2017-2022) & (US$ Million)
Table 104. Roche Recent Development
Table 105. Scienion Company Details
Table 106. Scienion Business Overview
Table 107. Scienion HIV-AIDS Testing Product
Table 108. Scienion Revenue in HIV-AIDS Testing Business (2017-2022) & (US$ Million)
Table 109. Scienion Recent Development
Table 110. Sequenom Company Details
Table 111. Sequenom Business Overview
Table 112. Sequenom HIV-AIDS Testing Product
Table 113. Sequenom Revenue in HIV-AIDS Testing Business (2017-2022) & (US$ Million)
Table 114. Sequenom Recent Development
Table 115. SeraCare Company Details
Table 116. SeraCare Business Overview
Table 117. SeraCare HIV-AIDS Testing Product
Table 118. SeraCare Revenue in HIV-AIDS Testing Business (2017-2022) & (US$ Million)
Table 119. SeraCare Recent Development
Table 120. Siemens Company Details
Table 121. Siemens Business Overview
Table 122. Siemens HIV-AIDS Testing Product
Table 123. Siemens Revenue in HIV-AIDS Testing Business (2017-2022) & (US$ Million)
Table 124. Siemens Recent Development
Table 125. Takara Bio Company Details
Table 126. Takara Bio Business Overview
Table 127. Takara Bio HIV-AIDS Testing Product
Table 128. Takara Bio Revenue in HIV-AIDS Testing Business (2017-2022) & (US$ Million)
Table 129. Takara Bio Recent Development
Table 130. Research Programs/Design for This Report
Table 131. Key Data Information from Secondary Sources
Table 132. Key Data Information from Primary Sources
List of Figures
Figure 1. HIV-AIDS Testing Product Picture
Figure 2. Global HIV-AIDS Testing Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global HIV-AIDS Testing Market Size 2017-2028 (US$ Million)
Figure 4. United States HIV-AIDS Testing Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 5. United States HIV-AIDS Testing Market Size 2017-2028 (US$ Million)
Figure 6. United States HIV-AIDS Testing Market Share in Global 2017-2028
Figure 7. HIV-AIDS Testing Report Years Considered
Figure 8. Product Picture of Kits and Reagents
Figure 9. Product Picture of Instruments
Figure 10. Product Picture of Others
Figure 11. Global HIV-AIDS Testing Market Share by Type in 2022 & 2028
Figure 12. Global HIV-AIDS Testing Market Size by Type (2017-2028) & (US$ Million)
Figure 13. Global HIV-AIDS Testing Market Share by Type (2017-2028)
Figure 14. United States HIV-AIDS Testing Market Share by Type in 2022 & 2028
Figure 15. United States HIV-AIDS Testing Market Size by Type (2017-2028) & (US$ Million)
Figure 16. United States HIV-AIDS Testing Market Share by Type (2017-2028)
Figure 17. Product Picture of Hospitals
Figure 18. Product Picture of Private Diagnostics Laboratories
Figure 19. Product Picture of Academic and Research Institutes
Figure 20. Product Picture of Others
Figure 21. Global HIV-AIDS Testing Market Share by Application in 2022 & 2028
Figure 22. Global HIV-AIDS Testing Market Size by Application (2017-2028) & (US$ Million)
Figure 23. Global HIV-AIDS Testing Market Share by Application (2017-2028)
Figure 24. United States HIV-AIDS Testing Market Share by Application in 2022 & 2028
Figure 25. United States HIV-AIDS Testing Market Size by Application (2017-2028) & (US$ Million)
Figure 26. United States HIV-AIDS Testing Market Share by Application (2017-2028)
Figure 27. North America HIV-AIDS Testing Market Size Growth Rate 2017-2028 (US$ Million)
Figure 28. U.S. HIV-AIDS Testing Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 29. Canada HIV-AIDS Testing Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 30. Europe HIV-AIDS Testing Market Size Growth Rate 2017-2028 (US$ Million)
Figure 31. Germany HIV-AIDS Testing Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 32. France HIV-AIDS Testing Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 33. U.K. HIV-AIDS Testing Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 34. Italy HIV-AIDS Testing Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 35. Russia HIV-AIDS Testing Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 36. Asia-Pacific HIV-AIDS Testing Market Size Growth Rate 2017-2028 (US$ Million)
Figure 37. China HIV-AIDS Testing Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 38. Japan HIV-AIDS Testing Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 39. South Korea HIV-AIDS Testing Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 40. India HIV-AIDS Testing Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 41. Australia HIV-AIDS Testing Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 42. Taiwan HIV-AIDS Testing Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 43. Indonesia HIV-AIDS Testing Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 44. Thailand HIV-AIDS Testing Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 45. Malaysia HIV-AIDS Testing Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 46. Philippines HIV-AIDS Testing Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 47. Latin America HIV-AIDS Testing Market Size Growth Rate 2017-2028 (US$ Million)
Figure 48. Mexico HIV-AIDS Testing Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 49. Brazil HIV-AIDS Testing Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 50. Argentina HIV-AIDS Testing Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 51. Middle East & Africa HIV-AIDS Testing Market Size Growth Rate 2017-2028 (US$ Million)
Figure 52. Turkey HIV-AIDS Testing Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 53. Saudi Arabia HIV-AIDS Testing Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 54. U.A.E HIV-AIDS Testing Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 55. Abbott Revenue Growth Rate in HIV-AIDS Testing Business (2017-2022)
Figure 56. Affymetrix Revenue Growth Rate in HIV-AIDS Testing Business (2017-2022)
Figure 57. Beckman Coulter/Danaher Revenue Growth Rate in HIV-AIDS Testing Business (2017-2022)
Figure 58. Becton Dickinson Revenue Growth Rate in HIV-AIDS Testing Business (2017-2022)
Figure 59. bioMerieux Revenue Growth Rate in HIV-AIDS Testing Business (2017-2022)
Figure 60. Bio-Rad Revenue Growth Rate in HIV-AIDS Testing Business (2017-2022)
Figure 61. Cepheid Revenue Growth Rate in HIV-AIDS Testing Business (2017-2022)
Figure 62. Diamedix Revenue Growth Rate in HIV-AIDS Testing Business (2017-2022)
Figure 63. DiaSorin Revenue Growth Rate in HIV-AIDS Testing Business (2017-2022)
Figure 64. Eiken Chemical Revenue Growth Rate in HIV-AIDS Testing Business (2017-2022)
Figure 65. Elitech Group Revenue Growth Rate in HIV-AIDS Testing Business (2017-2022)
Figure 66. Enzo Biochem Revenue Growth Rate in HIV-AIDS Testing Business (2017-2022)
Figure 67. Fujirebio Revenue Growth Rate in HIV-AIDS Testing Business (2017-2022)
Figure 68. Lonza Revenue Growth Rate in HIV-AIDS Testing Business (2017-2022)
Figure 69. Roche Revenue Growth Rate in HIV-AIDS Testing Business (2017-2022)
Figure 70. Scienion Revenue Growth Rate in HIV-AIDS Testing Business (2017-2022)
Figure 71. Sequenom Revenue Growth Rate in HIV-AIDS Testing Business (2017-2022)
Figure 72. SeraCare Revenue Growth Rate in HIV-AIDS Testing Business (2017-2022)
Figure 73. Siemens Revenue Growth Rate in HIV-AIDS Testing Business (2017-2022)
Figure 74. Takara Bio Revenue Growth Rate in HIV-AIDS Testing Business (2017-2022)
Figure 75. Bottom-up and Top-down Approaches for This Report
Figure 76. Data Triangulation
Figure 77. Key Executives Interviewed

REPORT PURCHASE OPTIONS

USD Single User Price
USD Multi User Price
USD Enterprise Price

---- OR ----

Frequently Asked Questions ?

  • Upto 24 hrs - Working days
  • Upto 48 hrs max - Weekends and public holidays
  • Single User License
    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License
    A license granted to multiple users.

  • Site License
    A license granted to a single business site/establishment.

  • Corporate License, Global License
    A license granted to all employees within organisation access to the product.
  • Online Payments with PayPal and CCavenue
  • Wire Transfer/Bank Transfer
  • Email
  • Hard Copy

Our Key Features

  • Data Accuracy and Reliability
  • Data Security
  • Customized Research
  • Trustworthy
  • Competitive Offerings
check discount